Displaying drugs 101 - 125 of 135 in total
| DrugBank ID | Name CAS Number |
Weight Formula |
Structure | Categories | Therapeutic Indication |
|---|---|---|---|---|---|
| DB00094 |
Urofollitropin
146479-72-3 |
980.1620 C42H65N11O12S2 |
|
Fertility Agents | For treatment of female infertility |
| DB00038 |
Oprelvekin
145941-26-0 |
19047.2000 C854H1411N253O235S2 |
|
Coagulants / Thrombotics | Increases reduced platelet levels due to chemotherapy |
| DB00089 |
Capromab
145464-28-4 |
|
Imaging Agents | For diagnosis of prostate cancer and detection of intra-pelvic metastases. | |
| DB00060 |
Interferon beta-1a
145258-61-3 |
20027.0000 C908H1408N246O252S7 |
|
Antiviral Agents / Immunomodulatory Agents | For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum |
| DB00068 |
Interferon beta-1b
145155-23-3 |
20011.0000 C908H1408N246O253S6 |
|
Antiviral Agents / Immunomodulatory Agents | Interferon beta-1b is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease... |
| DB00054 |
Abciximab
143653-53-6 |
145651.1000 C6462H9964N1690O2049S48 |
|
Anticoagulants / Antiplatelet Agents | Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergo... |
| DB00026 |
Anakinra
143090-92-0 |
17257.6000 C759H1186N208O232S10 |
|
Antirheumatic Agents / Immunomodulatory Agents | For the treatment of adult rheumatoid arthritis. |
| DB00099 |
Filgrastim
143011-72-7 |
18802.8000 C845H1343N223O243S9 |
|
Anti-Infective Agents / Antineutropenic Agents / Immunomodulatory Agents | Increases leukocyte production, for treatment in non-myeloid cancer, neutropenia and bone marrow transplant. |
| DB00053 |
Imiglucerase
143003-46-7 |
55597.4000 C2532H3854N672O711S16 |
|
Enzyme Replacement Agents | For the treatment of Gaucher's disease (deficiency in glucocerebrosidase) |
| DB01276 |
Exenatide
141758-74-9 |
4186.6000 C184H282N50O60S |
|
Indicated as adjunctive therapy to improve glycemic control in patients with Type 2 diabetes mellitus who are taking metformin, a sulfonylurea, or ... | |
| DB00075 |
Muromonab
140608-64-6 |
146189.7000 C6460H9946N1720O2043S56 |
|
Immunomodulatory Agents / Immunosuppressive Agents | For treatment of organ transplant recipients, prevention of organ rejection |
| DB00027 |
Gramicidin D
1405-97-6 |
1882.2947 C99H140N20O17 |
|
Anti-Infectives / Antibiotic Agents / Ophthalmic Antibiotic / Topical Antibiotic / Antibiotics | For treatment of skin lesions, surface wounds and eye infections |
| DB00057 |
Satumomab Pendetide
138955-26-7 |
141478.9000 C6268H9708N1666O1971S48 |
|
Imaging Agents | For diagnosis of extrahepatic malignant cancers |
| DB00049 |
Rasburicase
134774-45-1 |
34109.5000 C1521H2381N417O461S7 |
|
Antihyperuricemic Agents | For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy) |
| DB00015 |
Reteplase
133652-38-7 |
39589.6000 C1736H2671N499O522S22 |
|
Thrombolytic Agents | For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction |
| DB00046 |
Insulin Lispro
133107-64-9 |
5808.0000 C257H387N65O76S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 or 2 diabetes mellitus. To be used in conjunction with an intermediate or long-acting insulin except when used in a con... |
| DB00059 |
Pegaspargase
130167-69-0 |
31731.9000 C1377H2208N382O442S17 |
|
Antineoplastic Agents | For treatment of acute lymphoblastic leukemia |
| DB00006 |
Bivalirudin
128270-60-0 |
2180.2853 C98H138N24O33 |
|
Anticoagulants / Antithrombotic Agents | For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing p... |
| DB00052 |
Somatropin recombinant
12629-01-5 |
22129.0000 C990H1532N262O300S7 |
|
Anabolic Agents / Hormone Replacement Agents | For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss |
| DB04899 |
Nesiritide
124584-08-3 |
3464.0000 |
|
Cardiac drugs | For the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity. |
| DB00001 |
Lepirudin
120993-53-5 |
6963.4250 C287H440N80O110S6 |
|
Anticoagulants / Antithrombotic Agents / Fibrinolytic Agents | For the treatment of heparin-induced thrombocytopenia |
| DB00069 |
Interferon alfacon-1
118390-30-0 |
19343.0000 C860H1353N227O255S9 |
|
Antineoplastic Agents / Antiviral Agents / Immunomodulatory Agents | For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma |
| DB01306 |
Insulin Aspart
116094-23-6 |
C256H381N65O79S6 |
|
Antidiabetic / Hypoglycemic Agents | For the treatment of Type 1 or 2 diabetes mellitus. Should normally be used in conjunction with an intermediate or long-acting insulin. |
| DB00016 |
Epoetin alfa
113427-24-0 |
18396.1000 C815H1317N233O241S5 |
|
Antianemic Agents | For treatment of anemia (from renal transplants or certain HIV treatment) |
| DB00012 |
Darbepoetin alfa
11096-26-7 |
18396.1000 C815H1317N233O241S5 |
|
Antianemic Agents | For the treatment of anemia (from renal transplants or certain HIV treatment) |
Displaying drugs 101 - 125 of 135 in total